IN VITRO METHOD FOR THE DIAGNOSIS OR PROGNOSIS OF BREAST CANCER

Patent number:

EP21382448

Galicia.svg
No items found.

The present invention refers to an in vitro method for the diagnosis and/or prognosis of breast cancer. The method of the invention is carried out by determining the concentration level of proteins in erythrocytes or red blood cells (RBCs) comprised in patient blood samples.

Countries:
Spain
Regions:
Galicia
Centers:
SERVIZO GALEGO DE SAUDE, UNIVERSIDAD DE SANTIAGO DE COMPOSTELA, OTHER
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
SDG03: Good health and well-being
Applications

These types of biomarkers could help detecting metastatic breast cancer early and non-invasively, reducing costs and influencing directly on the patients quality of life. These biomarkers would allow to adapt the treatments to the phase of the disease, avoiding unnecessary treatments and reducing the levels of toxicity or secondary effects.

Comments

Other related patents

Health

PEPTIDE AND PHARMACEUTICAL COMPOSITIONS OF SAME FOR USE AS AN ANTIMICROBIAL AND IN CANCER TREATMENT

Countries
Spain
Know more
Health

METHOD FOR THE CLINICAL EVALUATION OF THE SPEECH SYSTEM OF PATIENTS WITH LARYNGEAL PATHOLOGIES THROUGH AN ACOUSTIC EVALUATION OF VOICE QUALITY (MACHINE-TRANSLATION BY GOOGLE TRANSLATE, NOT LEGALLY BINDING)

Countries
Spain
Know more
Health
Chemicals

METHOD FOR THE DETECTION OF SARS-COV-2 BY DIGITAL PCR

Countries
Greece
Know more
Get back to patents directory